Publications
NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift (Mod Pathol 2023)
NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift (Mod Pathol 2023)
Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer (J IMMUNOTHER CANCER 2022)
Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer (J IMMUNOTHER CANCER 2022)
Multidisciplinary considerations in the management of breast cancer patients receiving neoadjuvant chemotherapy (curr probl surg 2022)
Multidisciplinary considerations in the management of breast cancer patients receiving neoadjuvant chemotherapy (curr probl surg 2022)
Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative Immunotherapy (ann surg oncol 2022)
Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative Immunotherapy (ann surg oncol 2022)
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit (jco precis oncol 2022)
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit (jco precis oncol 2022)
Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche (cell 2022)
Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche (cell 2022)
Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial (jama oncol 2020)
Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial (jama oncol 2020)
Retinoblastoma protein expression and its predictors in triple-negative breast cancer (npj breast cancer 2020)
Retinoblastoma protein expression and its predictors in triple-negative breast cancer (npj breast cancer 2020)
A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer (clin breast cancer 2020)
A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer (clin breast cancer 2020)
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis (ann rheum dis 2020)
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis (ann rheum dis 2020)
Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes (infect immun 2018)
Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes (infect immun 2018)
ERK Signaling Is Essential for Macrophage Development (plos 0ne 2015)
ERK Signaling Is Essential for Macrophage Development (plos 0ne 2015)
Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells (Infect immun 2015)
Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells (Infect immun 2015)
Mycobacterium tuberculosis lipoprotein LprG binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion (plos pathog 2014)
Mycobacterium tuberculosis lipoprotein LprG binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion (plos pathog 2014)
First documentation of isoniazid reversion in Mycobacterium tuberculosis (Int j tuberc lung dis 2009)
First documentation of isoniazid reversion in Mycobacterium tuberculosis (Int j tuberc lung dis 2009)
Rapid Identification of Mycobacterium tuberculosis and Nontuberculous Mycobacteria by Multiplex, Real-Time PCR (j clin microbiol 2009)
Rapid Identification of Mycobacterium tuberculosis and Nontuberculous Mycobacteria by Multiplex, Real-Time PCR (j clin microbiol 2009)